Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

NICE recommends QRisk should replace Framingham risk score for predicting cardiovascular disease

EMIS : 15 February, 2008  (New Product)
A pioneering research project, QRisk, based on real-life primary care data is set to improve national diagnosis rates for cardiovascular disease (CVD) and potentially could save thousands of lives.
QResearch a not-for-profit partnership between the University of Nottingham and leading primary care system supplier, EMIS, which has created one of the world’s largest primary care research databases, undertook the Qrisk project.

The QRisk project analysed 20 years of data from almost three million UK patients to produce a new equation to help doctors identify those most at risk of developing CVD.

The National Institute for Clinical Excellence (NICE) has now recommended that the formula be adopted across medical practice in England and Wales replacing the current standard guidance for predicting CVD, the Framingham risk score.

In a new public consultation document, NICE said: “Emerging evidence suggests that QRisk gives a better estimation of risk in the general population of England and Wales than the Framingham equations.”

QRisk project leader ,professor Julia Hippisley-Cox, of the University of Nottingham, said: “This is a landmark decision that opens the way for our research to make a real difference to patient care.”

“If adopted nationally, we estimate that QRisk could save many thousands of lives by more accurately identifying those at risk. It will also improve the quality of day-to-day life for many patients.”

“Once NICE has finalised their guidance, our key task will be to ensure that colleagues can easily implement QRisk within clinical practice and we are developing software that will make this possible.”

Dr David Stables, clinical director of EMIS and a director of QResearch, said: “This is a powerful example of how data captured in the process of caring for the individual patient can be used to improve healthcare for all.”

“It is also a tribute to the thousands of working GPs who freely contribute their data to QResearch; without their co-operation, projects like QRisk could not happen.”

The QRisk model is significantly different from the Framingham risk score in a number of key areas predicting that a smaller percentage of the population is at risk of CVD but critically that very different populations are at risk.

Specifically, it found that women and people living in deprived areas were at far greater risk than predicted by Framingham, which was based on a small US study from more than 30 years ago.

Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo